Pulmonary hypertension associated with antisynthetase syndrome: insights from the ASPIRE registry

Clicks: 19
ID: 339761
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #107 of 164 articles by views in Rheumatology Advances in Practice

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 164 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Objectives To assess the characteristics and outcomes in patients with Pulmonary Hypertension (PH) associated with Antisynthetase syndrome (ASyS). Methods Data for 88 ASyS patients assessed between 2000 and 2022 were obtained from the ASPIRE (Assessing the Spectrum of PH identified at a Referral centre) registry. Patients with pre-capillary PH were matched for age, sex and severity of PH with systemic sclerosis controls on a 1:1 basis. Results 64 patients had pre-capillary PH, 9 PH associated with left heart disease and 15 had no/unclassified-PH. Jo-1 was the most common antibody and was present more frequently in pre-capillary PH. Most patients had interstitial lung disease; nonspecific interstitial pneumonia was most common. Jo-1 antibodies were associated with an increased risk of PH and of more severe lung disease. Patients with pre-capillary PH had significantly worse spirometry, diffusing capacity of the lungs for carbon monoxide (DLco) and a trend towards more extensive interstitial lung disease than patients with no/unclassified-PH. In patients with ASyS-PH, higher age and increased pulmonary vascular resistance were independent predictors of mortality. 10-year survival was significantly worse in patients with pre-capillary PH than no/unclassified-PH. Despite less favourable spirometry, 10-year survival was significantly better in ASyS-PH than in systemic sclerosis-associated PH. Conclusion Most patients with ASyS-PH have parenchymal lung disease. Age and pulmonary vascular resistance are important prognostic predictors. Survival in ASyS-PH is superior to that of systemic sclerosis-associated pre-capillary PH.
Reference Key
openalex_W7226033767 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Rheumatology Advances in Practice
Year 2026
DOI
10.1093/rap/rkag147
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.